SCHEMBL30794471

SCHEMBL30794471

O=C1N[C@H](c2cc(C#Cc3ccc(F)cc3)ccn2)[C@@H](c2ccc(F)cc2)O1

nearest known ligand 0.77

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 20/20 0.77
PGR P06401 1/20 0.44
KCNH2 Q12809 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4537146 1.00 GRM5 (0.77) GRM5PGRKCNH2
SCHEMBL4543610 1.00 GRM5 (0.77) GRM5PGRKCNH2
SCHEMBL4543623 0.95 GRM5 (0.85) GRM5PGRKCNH2
SCHEMBL4559952 0.95 GRM5 (0.85) GRM5PGRKCNH2
SCHEMBL4538693 0.95 GRM5 (0.69) GRM5PGRKCNH2
SCHEMBL13640407 0.95 GRM5 (0.69) GRM5PGRKCNH2
SCHEMBL4537773 0.92 GRM5 (0.72) GRM5PGRKCNH2
SCHEMBL30796545 0.92 GRM5 (0.72) GRM5PGRKCNH2
SCHEMBL4534268 0.92 GRM5 (0.72) GRM5PGRKCNH2
SCHEMBL4542477 0.90 GRM5 (0.69) GRM5PGRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584250-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS Biohaven Therapeutics Ltd. (VG) 2025-07-16 EP disclosed
WO-2024054811-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD. (VG) 2024-03-14 WO disclosed